Abstract:Background: Primary lymphoma of bone (PLB) is an extremely rare malignancy arising in the skeletal system. There is no consensus over the best definition of PLB. Most of the published articles are single-institutional retrospective studies with a limited sample size. The rarity of PLB and discrepancies on diagnostic criteria has resulted in a vague understanding of PLB. Methods We retrospectively analyzed the clinical characteristics and prognostic factors of 2558 PLB patients who were registered in the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2016. Survival rates were calculated using the Kaplan–Meier method. The effects of various factors on survival outcomes were analyzed by using the log-rank test. Univariate and multivariate analyses were conducted by using the Cox proportional hazards model to determine independent prognostic factors. Results: The median follow-up time of all eligible patients was 58 months. There seemed no sex preponderance in PLB incidence. The most involved sites are axial skeletons. The most common histological subtype was diffuse large B-cell lymphoma. The 3-, 5-, 10-, and 20-year overall survival (OS) rates were 70.70%, 65.70%, 54.40% and 39.50%, respectively. PLB patients whose primary tumor sites were appendicular and craniofacial skeletons had a significant survival advantage [hazard ratio (HR) = 0.694, 95% confidence interval (CI) 0.552–0.872; HR = 0.729, 95% CI 0.597–0.889, respectively] over those with axial skeletons as primary tumor sites. Patients with Hodgkin lymphoma, non-Hodgkin lymphoma (NHL)–mature B-cell lymphoma, and NHL-precursor-cell lymphoblastic lymphoma also had a significant OS advantage (HR = 0.392, 95% CI 0.200–0.771; HR = 0.826, 95% CI 0.700–0.973; and HR = 0.453, 95% CI 0.223–0.923, respectively). Patients with Ann Arbor stage III–IV at diagnosis were at higher risk of death than those with stage I–II (HR = 1.348, 95% CI 1.107–1.641). Chemotherapy was an independent favorable prognostic factor (HR = 0.734, 95% CI 0.605–0.890). Conclusions: Primary anatomic site, histology type, higher Ann Arbor stage and chemotherapy were independent prognostic factors. Chemotherapy played a pivotal role in PLB treatment.

Primary lymphoma of bone:A clinicopathologic and immunohistochemical observation

Primary lymphoma of bone: a case report and review of the literature

Primary lymphoma of bone:report of one case and review of literature

[Clinical Features of 11 Cases of Primary Bone Lymphoma].

Clinical Features and Treatment of Primary Non-Hodgkin Lymphoma of Bone

Primary Lymphoma of Bone: a Population-Based Study of 2558 Patients.

Clinical and pathological characteristics of primary bone lymphoma

Clinical Characterization and Prognostic Factors of Primary Lymphoma of Bone in Case of Chinese Patients

Primary Bone Lymphoma: A Review of the Literature with Emphasis on Histopathology and Histogenesis

Clinical analysis of primary bone lymphoma:report of 42 cases

Primary bone lymphoma: Clinical presentation and therapeutic considerations

[Clinical Analysis of 13 Patients with Primary Bone Lymphoma].

Primary Lymphoma Of The Tibia In Children Two Case Reports

Follicular Lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases

Primary diffuse large B-cell lymphoma of bone in adults: A SEER population-based study

[Primary Lymphoma of Breast: a Clinicopathologic, Immunophenotypic and Prognostic Study of 21 Cases].

The clinical features and prognostic factors of primary and secondary bone lymphoma

MRI Findings of Primary Lymphoma of Bone

Plasmablastic Lymphoma:A Clinicopathologic Analysis of 11 Cases with Review of Literature

Clinicopathological features of oral cavity primary plasmablastic lymphoma

Analysis of Diagnosis and Treatment of 12 Cases of Primary Lymphoma of Bone